EX-99.1 14 d142578dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

April 14, 2016

CONSENT OF DR. J. GREGORY WIRTH

United States Securities and Exchange Commission

In connection with UroGen Pharma Ltd.’s (the “Company”) Registration Statement on Form F-1 (the “Registration Statement”), I, Dr. J. Gregory Wirth, hereby consent to the inclusion in the Company’s Registration Statement of the following:

 

  1. Images showing pre-treatment and post-MitoGel treatment results from one low-grade UTUC patient in the Compassionate Use program.

 

Yours truly,

/s/ Dr. J. Gregory Wirth

Dr. J. Gregory Wirth